Clinical trial · Interventional
INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to characterize baseline multidisciplinary tumor board (MDTB) context and variability, evaluate the relationship between baseline fitness of patients with cancer and initial treatment recommendations, and assess the impact of the INSPIRE intervention, which involves including electronic patient reported outcomes (ePROs) within MDTB on MDTB discussion content, provider burden, treatment recommended and received, healthcare utilization, and patient-reported outcomes.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Corpus Uteri Cancer | Malignant Uterine Corpus Neoplasm | ALIAS | 0.90 |
| Other Female Genital Malignant Neoplasms | — | UNRESOLVED | — |
| Ovary Cancer | — | UNRESOLVED | — |
| Pancreas Cancer | Pancreatic Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Capture of patient-reported outcomes | Behavioral | — | UNRESOLVED |
| Enhanced Clinician Awareness | Behavioral | — | UNRESOLVED |
| INSPIRE (INtegrating Systematic PatIent-Reported Evaluations) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Group A- Enhanced Usual Care
- description
- Patient-reported outcomes captured; no data presented in any multidisciplinary tumor board. This group is a historical control.
- interventionNames
- Behavioral: Capture of patient-reported outcomes
- type
- ACTIVE_COMPARATOR
- label
- Group B- Enhanced Clinician Awareness
- description
- Patient-reported outcomes (PROs) captured with no personal data presented to multidisciplinary tumor board; other patient's PROs may be presented. This groups is a contemporary control.
- interventionNames
- Behavioral: Capture of patient-reported outcomes
- Behavioral: Enhanced Clinician Awareness
- type
- EXPERIMENTAL
- label
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion/Exclusion Criteria: We will include two populations: (1) patients and (2) clinical team members involved in the MDTB. Inclusion Criteria: * Inclusions Criteria- Patients: 1. aged 18 years or older; 2. with suspected or confirmed diagnosis of pancreatic, breast, and gynecologic cancer (all stages) within 8 weeks of diagnosis; 3. intention to be treated at a participating institution; 4. with verbal fluency in English or Spanish; and 5. scheduled to be discussed at MDTB. * Inclusion criteria - Clinicians: All clinical team members participating in the pancreatic, breast, or gynecologic MDTB at a participating site will be included and have pre-emptively agreed to participation. Exclusion Criteria: * Exclusion criteria - Patients: Individuals with plans to receive cancer treatment outside the participating institution and inability to speak English or Spanish. * Exclusion criteria - Clinician: Clinicians will retain the opportunity to opt-out of participation, in which case their portions of the discussion will not be included in the analysis; however, this is not anticipated based on pilot data.
References
Publications (0)
Data not yet available